HALIODX
HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.
HALIODX
Industry:
Health Diagnostics Medical Pharmaceutical
Founded:
2014-01-01
Address:
Marseille, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.haliodx.com
Total Employee:
51+
Status:
Active
Contact:
+33 (0) 4 91 29 30 90
Total Funding:
26.5 M EUR
Technology used in webpage:
SPF Mobile Non Scaleable Content IPv6 HubSpot CMS Hub Smart App Banner OVH Barracuda Networks OzServers Gandi.net DNS Lemlist
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
Quest for Growth
Quest for Growth investment in Series B - HalioDx
BNP Paribas Développement
BNP Paribas Développement investment in Series B - HalioDx
PSIM fund
PSIM fund investment in Series B - HalioDx
Sham Innovation Santé
Sham Innovation Santé investment in Series B - HalioDx
MI Care
MI Care investment in Series B - HalioDx
Sofipaca
Sofipaca investment in Series B - HalioDx
Turenne Capital
Turenne Capital investment in Series A - HalioDx
Newest Events participated
More informations about "HalioDx"
HalioDx - Crunchbase Company Profile & Funding
HalioDx may be growing as indicated by the acquisition by Veracyte, which is expected to drive international market growth. The acquisition is a strategic move that suggests an expansion of …See details»
Veracyte global diagnostics company
Feb 3, 2022 Veracyte is a pioneering global diagnostics company. Our molecular tests empower clinicians with high-value insights in the race to diagnose and treat cancer.See details»
HalioDx - Overview, News & Similar companies | ZoomInfo.com
Aug 3, 2021 View HalioDx (www.haliodx.com) location in Provence-Alpes-Cote d'Azur, France , revenue, industry and description. Find related and similar companies as well as employees …See details»
HALIODX INC. Company Profile | South San Francisco, CA
Find company research, competitor information, contact details & financial data for HALIODX INC. of South San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
HalioDx SAS - life-sciences-europe.com
Mar 23, 2015 HalioDx is an immuno-oncology diagnostic company providing oncologists with first-in-class immune-based diagnostic products and services to guide cancer care and …See details»
HalioDX Locations - Contract Research Map
HalioDx executes biomarker studies and companion diagnostic assay development in conformity with regulations and in partnership with biopharmaceutical companies.See details»
HalioDX | Scientist.com
Thanks to the pioneering work of Jérôme Galon, HalioDx provides a unique range of immune scoring solutions based on the analysis and the understanding of the immune contexture of …See details»
Early Detection & Advanced Treatment: HALO …
Saving Lives With Early Disease Detection. We provide rapid, precise, and actionable results that create life-changing and life-saving individualized plans for patients.See details»
Veracyte Completes Acquisition of HalioDx
We look forward to welcoming the talented HalioDx team to the Veracyte family and working together to build a leading global diagnostics company.” Bonnie Anderson, Veracyte’s …See details»
HalioDx - Contacts, Employees, Board Members, Advisors & Alumni
HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.See details»
HalioDx - Funding, Financials, Valuation & Investors
HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.See details»
HalioDx and Veracyte set proposed acquisition terms
Jun 1, 2021 About HalioDx HalioDx is an immuno-oncology diagnostic company providing oncologists and drug development organizations with first-in-class Immune-based diagnostic …See details»
HalioDx - VentureRadar
"HalioDx is an immuno-oncology diagnostic company providing oncologists with first-in-class Immune-based diagnostic products and services to guide cancer care and contribute to …See details»
HalioDx - YouTube
HalioDx is an immuno-oncology diagnostic company providing oncologists and Biopharma with first-in-class immune-based diagnostic products and services to guide cancer care and …See details»
HalioDx | Science Company | Labroots
Jul 7, 2020 Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate …See details»
Veracyte Completes Acquisition of HalioDx - Business Wire
Aug 3, 2021 Veracyte announced that the company has completed the acquisition of HalioDx.See details»
HalioDx Partners with DASA, the Largest Diagnostics Provider in …
Dec 10, 2020 HalioDx has rapidly become the preferred partner of Biopharma developing therapeutic antibodies, vaccines, chemotherapies, oncolytic peptides, and CAR-T cell …See details»
Immunoscore in Rectal Cancer - page.haliodx.com
Innovation Access Program in Rectal Cancer A time-limited program with preferential conditions for clinicians wishing to strengthen the patient-centric care.See details»
HalioDx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.See details»
Immunoscore in Colon Cancer Decision Impact program - HalioDx
Decision Impact program: a special initiative to enable an easy access to Immunoscore Colon and measure the medico-economic impact of Immunoscore application with physician own …See details»